Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

Report, Article English OPEN
Cheng, Minfeng; Gu, Huaying; Zheng, Liangrong; Wang, Houliang; Zhong, Zhiyong; Wen, Shenglin;
  • Publisher: Dove Press
  • Journal: Neuropsychiatric Disease and Treatment,volume 12,pages695-697 (issn: 1178-2021, eissn: 1178-2021)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.2147/NDT.S103687, pmc: PMC4820214
  • Subject: Schizophrenia. | Neurology. Diseases of the nervous system | Neurosciences. Biological psychiatry. Neuropsychiatry | Neuropsychiatric Disease and Treatment | Neuroleptic malignant syndrome | RC321-571 | RC346-429 | Case Report | Clozapine | schizophrenia | Withdrawal effect

Minfeng Cheng,* Huaying Gu,* Liangrong Zheng, Houliang Wang, Zhiyong Zhong, Shenglin Wen Department of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China *These authors contributed equally to this ... View more
  • References (13)
    13 references, page 1 of 2

    1. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65:464-470.

    2. Gambassi G, Capurso S, Tarsitani P, Liperoti R, Bernabei R. Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine. Aging Clin Exp Res. 2006;18:266-270.

    3. Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulted in delirium with psychosis: a report of three cases. J Clin Psychiatry. 1997;58:252-255.

    4. Lee JW, Robertson S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry. 1997;9:165-169.

    5. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870-876.

    6. Kawanishi C. Genetic predisposition to neuroleptic malignant syndrome: implications for antipsychotic therapy. Am J Pharmacogenomics. 2003;3:89-95.

    7. Khaldi S, Kornreich C, Choubani Z, Gourevitch R. Antipsychotiques atypiques et syndrome malin des neuroleptiques: brève revue de la littérature [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Encephale. 2008;34:618-624. French.

    8. Qureshi NA, Al-Habeeb TA. Sympathoadrenal hyperactivity and neuroleptic malignant syndrome. Am J Psychiatry. 2000;157:310-311.

    9. Gabellini AS, Pezzoli A, De Massis P, Casadei G, Grillo A, Sacquegna T. Neuroleptic malignant syndrome in an AIDS patient: clinical and pathological findings. Ital J Neurol Sci. 1994;15:293-295.

    10. Levitt AJ, Midha R, Craven JL. Neuroleptic malignant syndrome with intravenous haloperidol. Can J Psychiatry. 1990;35:789.

  • Related Organizations (2)
  • Metrics
Share - Bookmark